SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-23-002545
Filing Date
2023-02-27
Accepted
2023-02-27 16:04:15
Documents
14
Period of Report
2023-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K - Q4 2022 kdny-8k_20230227.htm   iXBRL 8-K 37830
2 EX-99.1 kdny-ex991_6.htm EX-99.1 339780
3 GRAPHIC gcjlz0m0j2gn000001.jpg GRAPHIC 67035
  Complete submission text file 0001564590-23-002545.txt   619010

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA kdny-20230227.xsd EX-101.SCH 5593
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20230227_lab.xml EX-101.LAB 19322
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20230227_pre.xml EX-101.PRE 11491
8 EXTRACTED XBRL INSTANCE DOCUMENT kdny-8k_20230227_htm.xml XML 3561
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37345 | Film No.: 23674702
SIC: 2834 Pharmaceutical Preparations